ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Short Communication

Open Vet J. 2025; 15(7): 3334-3340


The equine placental extract ameliorates renal damage in mice with adenine-induced chronic kidney disease by inhibiting indoxyl sulfate production

Koji Sugimoto, Junichi Nakamura, Dawei Deng, Eiichi Hirano.



Abstract
Download PDF Cited by 0 ArticlesPost

Background:
Indoxyl sulfate (IS) is a dietary metabolite of tryptophan produced in the liver. It is a uraemic toxin that facilitates the progression of chronic kidney disease (CKD). Previously, we had observed that equine placental extract (ePE) inhibited IS synthesis in an in vitro inhibition assay using the liver S9 fraction.

Aim:
The study was designed to investigate the effects of ePE on adenine-induced renal failure in mice at the histological and molecular levels to understand the mechanism of action of ePE.

Methods:
We assessed this effect through biochemical and histological in vivo analyses, using a CKD mouse and an adenine diet models, which induced renal damage through IS production.

Results:
ePE significantly suppressed serum, renal, and hepatic IS production in adenine diet-fed mice by inhibiting IS synthesis. Histological and semi-quantitative analyses using the tubulointerstitial injury index (TII) revealed that ePE effectively prevented the increase in adenine-induced mesangial-positive cell area. Additionally, ePE administration significantly suppressed adenine-induced renal fibrosis in mice. Moreover, immunohistochemical analysis demonstrated that ePE administration reduced the accumulation of F4/80-positive macrophages in the interstitial inflammatory infiltrates.

Conclusion:
These results suggest that ePE could ameliorate IS-associated renal injury in adenine diet-fed mice by reducing IS production in the interstitium of the kidneys.

Key words: Equine placental extract, Renal failure, Tubulointerstitial injury, Uremic toxin







Bibliomed Article Statistics

309
379
108
79
15
R
E
A
D
S

45

71

35

28

10
D
O
W
N
L
O
A
D
S
0809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.